In conclusion, our data suggest that while necessary, NRG1 positivity alone does not fully predict KTN3379 anti-tumor activity, but its activity was enriched in cell lines that expressed both NRG1 and high levels of AREG or TGFα. The gene discussed is AREG; the disease is neoplasm.